Konstantin Doronin

Title: Konstantin Doronin: Innovator in Anti-Cancer Research

Introduction

Konstantin Doronin is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of anti-cancer research, holding a total of 4 patents. His work focuses on developing novel vectors that can effectively target neoplastic cells.

Latest Patents

Doronin's latest patents include the development of replication-competent anti-cancer vectors. These innovative vectors are designed to be replication competent in neoplastic cells and overexpress an adenovirus death protein. Some of these vectors are specifically replication-restricted to neoplastic cells or to neoplastic alveolar type II cells. The patents also disclose compositions and methods aimed at promoting the death of neoplastic cells using these replication-competent vectors.

Career Highlights

Konstantin Doronin is affiliated with Saint Louis University, where he continues to advance his research in cancer therapies. His work has the potential to significantly impact the treatment of cancer by providing new avenues for targeted therapies.

Collaborations

Doronin collaborates with esteemed colleagues such as William S M Wold and Karoly Toth, contributing to a rich environment of innovation and research.

Conclusion

Konstantin Doronin's contributions to anti-cancer research through his innovative patents highlight his role as a leading inventor in the field. His work promises to pave the way for more effective cancer treatments in the future.